Solara Active Pharma Sciences Q1 FY27 Results: Net Profit Rises 55%, Revenue Jumps 19%
Solara Active Pharma Sciences Ltd. reported a strong set of consolidated results for the first quarter of FY27, driven by healthy revenue growth and improved operating profit. However, the company’s EBITDA margin declined slightly compared to the same period last year. The company posted consolidated revenue of ₹381 crore in …